Literature DB >> 26784265

Interleukin 33 is a guardian of barriers and a local alarmin.

Nikolas T Martin1, Michael U Martin2.   

Abstract

Interleukin 33 (IL-33) is a member of the IL-1 family of cytokines with a growing number of target cells and a plethora of biological functions. Although it has commonalities with other IL-1 cytokines, IL-33 exhibits some unique features. Here we review the biology of IL-33 and its receptor and develop a working model that describes two 'lives' for IL-33-one intracellular and one extracellular. Under healthy conditions, constitutively produced, intracellular IL-33 participates in maintaining barrier function by regulating gene expression as a nuclear protein. In parallel, nuclear IL-33 functions as a stored alarmin that is released when barriers are breached. Extracellular IL-33 coordinates immune defense and repair mechanisms while also initiating differentiation of helper T cells as the adaptive immune response is triggered.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26784265     DOI: 10.1038/ni.3370

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  160 in total

1.  Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.

Authors:  Laura Barreyro; Britta Will; Boris Bartholdy; Li Zhou; Tihomira I Todorova; Robert F Stanley; Susana Ben-Neriah; Cristina Montagna; Samir Parekh; Andrea Pellagatti; Jacqueline Boultwood; Elisabeth Paietta; Rhett P Ketterling; Larry Cripe; Hugo F Fernandez; Peter L Greenberg; Martin S Tallman; Christian Steidl; Constantine S Mitsiades; Amit Verma; Ulrich Steidl
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

3.  TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium.

Authors:  Lili Zhang; Rong Lu; Guiqiu Zhao; Stephen C Pflugfelder; De-Quan Li
Journal:  Int J Biochem Cell Biol       Date:  2011-06-12       Impact factor: 5.085

4.  Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain.

Authors:  Mélanie Pichery; Emilie Mirey; Pascale Mercier; Emma Lefrancais; Arnaud Dujardin; Nathalie Ortega; Jean-Philippe Girard
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

Review 5.  The enigmatic processing and secretion of interleukin-33.

Authors:  Weihua Zhao; Zhiqing Hu
Journal:  Cell Mol Immunol       Date:  2010-03-22       Impact factor: 11.530

6.  IL-33 activates tumor stroma to promote intestinal polyposis.

Authors:  Rebecca L Maywald; Stephanie K Doerner; Luca Pastorelli; Carlo De Salvo; Susan M Benton; Emily P Dawson; Denise G Lanza; Nathan A Berger; Sanford D Markowitz; Heinz-Josef Lenz; Joseph H Nadeau; Theresa T Pizarro; Jason D Heaney
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

7.  Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.

Authors:  Gaby Palmer; Dominique Talabot-Ayer; Céline Lamacchia; Dean Toy; Christian A Seemayer; Sébastien Viatte; Axel Finckh; Dirk E Smith; Cem Gabay
Journal:  Arthritis Rheum       Date:  2009-03

8.  Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.

Authors:  Hye Young Kim; Ya-Jen Chang; Srividya Subramanian; Hyun-Hee Lee; Lee A Albacker; Ponpan Matangkasombut; Paul B Savage; Andrew N J McKenzie; Dirk E Smith; James B Rottman; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2011-11-25       Impact factor: 10.793

9.  Pathogenic mouse hepatitis virus or poly(I:C) induce IL-33 in hepatocytes in murine models of hepatitis.

Authors:  Muhammad Imran Arshad; Solène Patrat-Delon; Claire Piquet-Pellorce; Annie L'helgoualc'h; Michel Rauch; Valentine Genet; Catherine Lucas-Clerc; Christian Bleau; Lucie Lamontagne; Michel Samson
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

10.  Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature.

Authors:  Svitlana Demyanets; Christoph Kaun; Richard Pentz; Konstantin A Krychtiuk; Sabine Rauscher; Stefan Pfaffenberger; Andreas Zuckermann; Arezu Aliabadi; Marion Gröger; Gerald Maurer; Kurt Huber; Johann Wojta
Journal:  J Mol Cell Cardiol       Date:  2013-04-06       Impact factor: 5.000

View more
  161 in total

1.  IL-33 induces immunosuppressive neutrophils via a type 2 innate lymphoid cell/IL-13/STAT6 axis and protects the liver against injury in LCMV infection-induced viral hepatitis.

Authors:  Yuejin Liang; Panpan Yi; Denley Ming Kee Yuan; Zuliang Jie; Zakari Kwota; Lynn Soong; Yingzi Cong; Jiaren Sun
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

2.  Effect of Coriolus versicolor glucan on the stimulation of cytokine production in sarcoma-180-bearing mice.

Authors:  Annoor Awadasseid; Kuugbee Eugene; Mayada Jamal; Jie Hou; Ahmed Musa Hago; Yaser Gamallat; Abdo Meyiah; Djibril Bamba; Chiwala Gift; Mohnad Abdalla; Yufang Ma; Yi Xin
Journal:  Biomed Rep       Date:  2017-10-11

3.  Immunological modulation following bone marrow-derived mesenchymal stromal cells and Th17 lymphocyte co-cultures.

Authors:  Mehdi Najar; Hussein Fayyad-Kazan; Wissam H Faour; Makram Merimi; Etienne M Sokal; Catherine A Lombard; Hassan Fahmi
Journal:  Inflamm Res       Date:  2018-11-30       Impact factor: 4.575

4.  IL-33: a jack of all trades in the orchestration of respiratory antibacterial immunity.

Authors:  Julia D Boehme; Dunja Bruder
Journal:  Cell Mol Immunol       Date:  2017-07-10       Impact factor: 11.530

5.  Prospects to translate the biology of IL-33 and ST2 during organ transplantation into therapeutics to treat graft-versus-host disease.

Authors:  Ian C Scott; Kirsty F Houslay; E Suzanne Cohen
Journal:  Ann Transl Med       Date:  2016-12

Review 6.  Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

Authors:  Ross John Porter; Caroline Andrews; Daniel Paul Brice; Scott Kenneth Durum; Mairi Hall McLean
Journal:  Inflamm Bowel Dis       Date:  2018-09-15       Impact factor: 5.325

7.  The Innate Immune Protein S100A9 Protects from T-Helper Cell Type 2-mediated Allergic Airway Inflammation.

Authors:  Lauren D Palmer; K Nichole Maloney; Kelli L Boyd; A Kasia Goleniewska; Shinji Toki; C Noel Maxwell; Walter J Chazin; R Stokes Peebles; Dawn C Newcomb; Eric P Skaar
Journal:  Am J Respir Cell Mol Biol       Date:  2019-10       Impact factor: 6.914

8.  Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors.

Authors:  Raul German Spallanzani; David Zemmour; Tianli Xiao; Teshika Jayewickreme; Chaoran Li; Paul J Bryce; Christophe Benoist; Diane Mathis
Journal:  Sci Immunol       Date:  2019-05-03

9.  CXCR6+ST2+ memory T helper 2 cells induced the expression of major basic protein in eosinophils to reduce the fecundity of helminth.

Authors:  Kazushige Obata-Ninomiya; Kenji Ishiwata; Hisanobu Nakano; Yusuke Endo; Tomomi Ichikawa; Atsushi Onodera; Kiyoshi Hirahara; Yoshitaka Okamoto; Hirotaka Kanuka; Toshinori Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

10.  Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility.

Authors:  Abigail E Russi; Mark E Ebel; Yuchen Yang; Melissa A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.